Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.475 USD | +3.15% | +1.66% | -19.89% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.89% | 208M | |
-24.66% | 7.76B | |
+69.23% | 4.33B | |
-3.68% | 2.64B | |
+3.74% | 2.63B | |
-46.17% | 2.16B | |
-14.34% | 1.75B | |
-20.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Canaccord Genuity Adjusts Price Target on Biodesix to $18 From $22, Reiterates Buy Rating